Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 46,500 KRW
Change Today -50.00 / -0.11%
Volume 15.6K
086450 On Other Exchanges
As of 2:24 AM 10/2/15 All times are local (Market data is delayed by at least 15 minutes).

dongkook pharmaceutical co l (086450) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/24/15 - 73,500
52 Week Low
12/15/14 - 33,100
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for DONGKOOK PHARMACEUTICAL CO L (086450)

Related News

No related news articles were found.

dongkook pharmaceutical co l (086450) Related Businessweek News

No Related Businessweek News Found

dongkook pharmaceutical co l (086450) Details

Dong Kook Pharmaceutical Co., Ltd. provides pharmaceutical products in South Korea and internationally. The company offers Alprostadil, Teicoplanin, Propofol, Triptorelin, Iopamidol, Octreotide LAR, Gadopentetate dimeglumine, Leuprorelin Acetate, Sodium Hyaluronate, and Streptokinase injection products; and health care products comprising Gamma Linolenic acid, Spirulina, calcium tablets, Propolis liquids and capsules, and Vital Joint Glucosamine products, as well as dietary supplements, multi-vitamins, and Omega-3 products. It also provides Bellast L24 and soft injection products, endoscopic trocar, and medical components, as well as stitches and staplers used for suturing in laparoscopic surgery or laparotomy, and devices for endoscope. The company was formerly known as UEC & Co., Ltd. and changed its name to Dong Kook Pharmaceutical Co., Ltd. in March 1982. Dong Kook Pharmaceutical Co., Ltd. was founded in 1968 and is based in Seoul, South Korea.

Founded in 1968

dongkook pharmaceutical co l (086450) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

dongkook pharmaceutical co l (086450) Key Developments

DONGKOOK Pharmaceutical Co., Ltd., Annual General Meeting, Mar 20, 2015

DONGKOOK Pharmaceutical Co., Ltd., Annual General Meeting, Mar 20, 2015., at 10:00 Korea Standard Time. Location: Auditorium Building B1. Agenda: To consider approval of financial statements for the year ended December 31, 2014; to consider appointment of directors; and to consider approval of the remuneration.

Probi Announces Distribution Agreement with Dongkook Pharmaceutical

Probi has signed a distribution agreement with Dongkook Pharmaceutical Co., Ltd. for the distribution of Probi's gut health product, Probi Mage®. The Product will be launched under Probi's brand in South Korea in the second quarter of 2014. Dongkook will launch Probi Mage® as a dietary supplement in department stores and TV/Internet home shopping.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
086450:KS 46,500.00 KRW -50.00

086450 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 086450.
View Industry Companies

Industry Analysis


Industry Average

Valuation 086450 Industry Range
Price/Earnings 18.3x
Price/Sales 1.7x
Price/Book 2.1x
Price/Cash Flow 18.0x
TEV/Sales 1.4x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DONGKOOK PHARMACEUTICAL CO L, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at